Our editors' QbD blog offers analysis and commentary on developing better pharmaceuticals with better science and better business in mind. Reader comments welcome.
QbD is being used to reassess traditional dissolution testing, for the betterment of product development, explains University of Alberta's Dr. Raimar Löbenberg.
OpEx and QbD, particularly the ideals of performance metrics and risk management, can be used to strengthen the relationship between partners in all pharmaceutical supply and contract situations. This webcast provides novel ideas and tangible suggestions for improving pharmaceutical partnerships.
Fiber optics provides for a greater level of information for formulation and method development, as well as routine analysis. Fiber optic systems also greatly reduce analyst time by performing calculations and managing reporting functions. Real-time data is also an advantage in comparing observations and analysis simultaneously, giving better clues into the behavior of a dosage form.
The key for survival is building the science and R&D
base for the long haul, pharma CEOs say. This PricewaterhouseCoopers survey
summary looks at CEOs’ aspirations, and fears, as they face the future, and how
pharma compares to other industries.
RSS
Create an Online Career Profile
Sign-up for Job Alerts
Utilize Career Resources
